Evaluation of a commercial targeted NGS panel for tumor mutation burden assessment in FFPE tissue

被引:1
|
作者
Fang, Peng [1 ]
Yan, Zhenyu [1 ]
Quyen Vu [2 ]
Smith, David [2 ]
Galderisi, Chad [2 ]
Spittle, Cynthia S. [1 ]
Li, Jin [1 ]
机构
[1] MolecularMD Corp, Cambridge, MA USA
[2] MolecularMD Corp, Portland, OR USA
关键词
D O I
10.1158/1538-7445.AM2018-3614
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3614
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Tumor Mutation Burden (TMB) Characterization Using a Small Panel
    Tang, Y.
    Li, Y.
    Huang, M.
    Hou, T.
    Lizaso, A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S45 - S45
  • [22] Utility Of A Comprehensive Cost-Effective Targeted DNA/RNA Panel (170 Genes) On A Next Generation Sequencing (NGS) Platform In Evaluation Of Melanoma For Tumor Specific Information, Microsatellite Instability (MSI) And Calculating The Overall Tumor Mutation Burden (TMB)
    Kolhe, Ravindra
    MOndal, Ashis
    Pundkar, Chetan
    Kota, Vamsi
    Chaubey, Alka
    MODERN PATHOLOGY, 2018, 31 : 201 - 201
  • [23] Utility Of A Comprehensive Cost-Effective Targeted DNA/RNA Panel (170 Genes) On A Next Generation Sequencing (NGS) Platform In Evaluation Of Melanoma For Tumor Specific Information, Microsatellite Instability (MSI) And Calculating The Overall Tumor Mutation Burden (TMB)
    Kolhe, Ravindra
    MOndal, Ashis
    Pundkar, Chetan
    Kota, Vamsi
    Chaubey, Alka
    LABORATORY INVESTIGATION, 2018, 98 : 201 - 201
  • [24] Determination of Tumor Mutation Burden Using a 500+Gene Pan-Cancer Comprehensive NGS Panel with Automated Variant Calling
    Gerding, Kelly
    Valkenburg, Kenneth
    Oliveras, Christina
    White, James
    Ettehadieh, Leila
    Cerqueira, Gustavo
    Gault, Christopher
    Hernandez, James
    Kong, Eric
    Angiuoli, Samuel
    Simmons, John
    Loftin, Isabell
    McElhinny, Abigail
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1456 - 1457
  • [25] Determination of Tumor Mutation Burden Using a 500+Gene Pan-Cancer Comprehensive NGS Panel with Automated Variant Calling
    Gerding, Kelly
    Valkenburg, Kenneth
    Oliveras, Christina
    White, James
    Ettehadieh, Leila
    Cerqueira, Gustavo
    Gault, Christopher
    Hernandez, James
    Kong, Eric
    Angiuoli, Samuel
    Simmons, John
    Loftin, Isabell
    McElhinny, Abigail
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1456 - 1457
  • [26] An evaluation of NGS to identify gene fusions using RNA from FFPE solid tumor samples
    Parks, Julianne Tdr
    Byron, Luo
    Crain, Brian
    June, Snedecor
    Chen, Zhao
    Du, Tingting
    Sica, Gabriel L.
    Owonikoko, Taofee K.
    Neill, Stewart G.
    Newman, Scott
    Saxe, Debra F.
    LoCoco, Jennifer S.
    Chuang, Han-Yu
    Lin, Charles
    Stephens, Kathryn M.
    Rossi, Michael R.
    Friedenberg, Matthew C.
    CANCER RESEARCH, 2016, 76
  • [27] Determining tumor mutation load using an NGS-based, target gene panel
    Machado, J. C.
    Reis, J.
    Fernandes, M.
    Silva, R.
    Cirnes, L.
    Chaudhary, R.
    Carneiro, F.
    Costa, J. L.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S4 - S5
  • [28] Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method
    Tang, Yuan
    Li, Yuli
    Wang, Weiya
    Lizaso, Analyn
    Hou, Ting
    Jiang, Lili
    Huang, Meijuan
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (01) : 71 - +
  • [29] Prediction of Tumor Mutation Burden in Lung Adenocarcinoma using a 130 Gene Targeted Sequencing Panel Covering 0.23 Megabases
    Joshi, R. P.
    Yang, S.
    Costa, H.
    Stehr, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 998 - 998
  • [30] Calculation of Mutational Burden in a Clinical Targeted Next-Generation Sequencing (NGS) Panel for Solid Tumors
    Velu, P.
    Bigdeli, A.
    Hess, P. R.
    Roth, J. J.
    Rosenbaum, J. N.
    Morrissette, J. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1024 - 1025